Tetrahydrocannabinol (THC)

1. Case report: Medical cannabis—warfarin drug-drug interaction - PMC

2. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics - PubMed

3. Observational study of medical marijuana as a treatment for treatment‐resistant epilepsies - Devinsky - 2022 - Annals of Clinical and Translational Neurology - Wiley Online Library

4. Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review - PubMed

5. Marijuana in Orthopaedics: Effects on Bone Health, Wound-Healing, Surgical Complications, and Pain Management - PubMed

6. UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes - PMC

7. The Efficacy of Cannabis in Reducing Back Pain: A Systematic Review - PMC

8. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: part 1 – continuous bivariate analysis - PMC

9. Thromboembolic Outcomes in Tetrahydrocannabinol-Positive Trauma Patients With Traumatic Brain Injury - PubMed

10. The endocannabinoid system and drug-associated contextual memories - PubMed

11. Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease - Holden - 2022 - Movement Disorders Clinical Practice - Wiley Online Library

12. Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003–2017 - PMC

13. Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest - PubMed

14. Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists - PubMed

15. Penile self-amputation due to cannabis-induced psychosis: a case report - PMC

16. Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review - PMC

17. Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports | SpringerLink

18. Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases - PMC

19. Marijuana toxicosis in dogs in Melbourne, Australia, following suspected ingestion of human faeces: 15 cases (2011-2020) - PubMed

20. Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report | Journal of Medical Case Reports | Full Text

21. The Origin and Biomedical Relevance of Cannabigerol - PubMed

22. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions - PubMed

23. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort | Journal of Cannabis Research | Full Text

24. Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis | Cannabis and Cannabinoid Research

25. Frontiers | Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice

26. What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps? - PMC

27. Cannabinoids Receptors in COVID-19: Perpetrators and Victims - PubMed

28. Adolescent e-cigarette or vaping product use-associated lung injury: A case series and review of the literature - PubMed

29. Marijuana and endothelial dysfunction: new mechanism and therapy - PubMed

30. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation - PMC

31. Drugs of Misuse: Focus on Vascular Dysfunction - Canadian Journal of Cardiology

32. The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System - PMC

33. Healthcare | Free Full-Text | Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis

34. Full article: E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

35. Cannabinoids, Insomnia, and Other Sleep Disorders - PubMed

36. (PDF) Cannabinoids as anticancer drugs: current status of preclinical research

37. Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum - PMC

38. Long‐term observational studies with cannabis‐based medicines for chronic non‐cancer pain: A systematic review and meta‐analysis of effectiveness and safety - Bialas - 2022 - European Journal of Pain - Wiley Online Library

39. Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation - PMC

40. Sex differences in medical cannabis-related adverse effects - PMC

41. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications | BMC Medicine | Full Text

42. In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center - PMC

43. Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature - PMC

44. Cannabis and the Violent Crime Surge - PMC

45. Protocol: Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol - PMC

46. Cannabis-Based Products for Chronic Pain: A Systematic Review: Annals of Internal Medicine: Vol 175, No 8

47. Impact of cannabinoids on pregnancy, reproductive health and offspring outcomes - PMC

48. TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids - PMC

49. Cannabis and the heart: unchartered territory - PubMed

50. Cureus | Cannabis and Its Potential Protective Role Against Inflammatory Bowel Disease: A Scoping Review | Article

51. The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use - PMC

52. Updates in the use of cannabis for insomnia - PubMed

53. Herbal Approaches to Pediatric Functional Abdominal Pain - PMC

54. Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC - Tagen - 2022 - British Journal of Pharmacology - Wiley Online Library

55. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination - PMC

56. Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty - PMC

57. Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know - PMC

58. Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome - PubMed

59. Frontiers | Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot

60. Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department - PMC

61. The effectiveness of inhaled Cannabis flower for the treatment of agitation/irritability, anxiety, and common stress | Journal of Cannabis Research | Full Text

62. Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series | Journal of Cannabis Research | Full Text

63. Use of cannabinoids for the treatment of patients with post-traumatic stress disorder - PubMed

64. Disentangling the lasting effects of adolescent cannabinoid exposure - PubMed

65. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis - PubMed

66. Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR - PubMed

67. Cannabis and Migraine: It's Complicated - PubMed

68. The antimicrobial effect behind Cannabis sativa - Schofs - 2021 - Pharmacology Research & Perspectives - Wiley Online Library

69. Cannabinoid Signalling in Immune–Reproductive Crosstalk during Human Pregnancy - PMC

70. Advancing the science on cannabis concentrates and behavioural health - PubMed

71. Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities - PMC

72. No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms - PubMed

73. Cannabis in Parkinson's Disease: The Patients' View - PubMed

74. A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis | Translational Psychiatry

75. THC and CBD effects on alcohol use among alcohol and cannabis co-users - PubMed

76. State of the science: cannabis and cannabinoids in palliative medicine-the potential - PubMed

77. Frontiers | Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain

78. Journal of Cancer Research and Therapeutics

79. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases - PubMed

80. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol - PubMed

81. Cannabinoids, reward processing, and psychosis - PubMed

82. Prospects for the Use of Cannabinoids in Psychiatric Disorders - PMC

83. Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients - PMC

84. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016 - PubMed

85. A Literature Review of Cannabis and Myocardial Infarction—What Clinicians May Not Be Aware Of - PMC

86. Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain - PubMed

87. Frontiers | Psychedelics for Brain Injury: A Mini-Review

88. Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand - PubMed

89. Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation - https://www.liebertpub.com/doi/pdf/10.1089/can.2021.0046

90. An Agathokakological Tale of Δ9-THC: Exploration of Possible Biological Targets - PubMed

91. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development - PMC

92. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis - PubMed

93. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review - PubMed

94. Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases - PubMed

95. The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System - PMC

96. Cannabis for Chronic Osteoarthritis Pain: A Case of an Older Person - PubMed

97. Cannabinoid Hyperemesis Syndrome in an Athlete | American Board of Family Medicine

98. Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies - PubMed

99. RACGP - A primer on medicinal cannabis safety and potential adverse effects

100. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update - ScienceDirect

101. Cureus | Chronic Marijuana Consumption Leading to High-Grade Atrioventricular Block in a Young Male | Article

102. JPM | Free Full-Text | The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations

103. Frontiers | Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

104. Application of medical cannabis in unstable angina and coron... : Medicine

105. Frontiers | Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers

106. Frontiers | Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review

107. Acute effects of partial CB1 receptor agonists on cognition - A meta-analysis of human studies - PubMed

108. Frontiers | Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs

109. Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review - ScienceDirect

110. Viruses | Free Full-Text | The Link between Cannabis Use, Immune System, and Viral Infections

111. IJMS | Free Full-Text | Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement

112. The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review - PMC

113. Evaluating the Safety of Cannabinoid-Based Medicines for Older Adults | Clinical Pharmacy and Pharmacology | JAMA Network Open | JAMA Network

114. Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control - PubMed

115. Seizure and Interictal Electroencephalographic (EEG) Changes with Cannabinoid Concentrate Use - PubMed

116. Cannabidiol for Mood Disorders: A Call for More Research - PMC

117. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment - PubMed

118. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment - PubMed

119. Cannabis based medicines and cannabis dependence: A critical review of issues and evidence - PMC

120. A Mini-Review of Relationships Between Cannabis Use and Neural Foundations of Reward Processing, Inhibitory Control and Working Memory - PMC

121. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies | Cannabis and Cannabinoid Research

122. Desistance, Self‐treatment, or Substitution: Decisions about Cannabis Use During Pregnancy - Greyson - 2021 - Journal of Midwifery & Women's Health - Wiley Online Library

123. Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review - PMC

124. A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates - PMC

125. Efficacy of cannabinoids against glioblastoma multiforme: A systematic review - PubMed

126. Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target - PubMed

127. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review - PubMed

128. Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review | BMJ Open

129. Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder - PubMed

130. Cannabis Exposure Decreases Need for Blood Pressure Support During General Anesthesia in Orthopedic Trauma Surgery | Cannabis and Cannabinoid Research

131. Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective - PMC

132. The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review - PubMed

133. Efficacy and safety of paediatric medicinal cannabis use: A scoping review - PMC

134. Development of central precocious puberty following cannabinoid use for paediatric epilepsy: causal or coincidence? | BMJ Case Reports

135. Analgesic Potential of Terpenes Derived from Cannabis sativa | Pharmacological Reviews

136. Perioperative Cannabis as a Potential Solution for Reducing Opioid and Benzodiazepine Dependence - PubMed

137. Electrochemical sensing: A prognostic tool in the fight against COVID-19 - PMC

138. A 20-Year-Old Man with e-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Thrombotic Coagulopathy - PMC

139. Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series - Stacy D’Andre, Sean McAllister, Jasdeepa Nagi, Karthik V. Giridhar, Eduardo Ruiz-Macias, Charles Loprinzi, 2021

140. :: JDAPM :: Journal of Dental Anesthesia and Pain Medicine

141. Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report - PMC

142. Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances - PMC

143. Cannabinoid control of hippocampal functions: the where matters - Robledo‐Menendez - 2022 - The FEBS Journal - Wiley Online Library

144. Current review of hemp-based medicines in dogs - PubMed

145. Topical and nutricosmetic products for healthy hair and dermal antiaging using “dual‐acting” (2 for 1) plant‐based peptides, hormones, and cannabinoids - PMC

146. A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options | Medical Principles and Practice | Karger Publishers

147. A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis | International Journal of MS Care

148. Perinatal Cannabis Exposures and Autism Spectrum Disorders - PMC

149. Cannabinoids and the eye - PubMed

150. Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland | SpringerLink

151. Cannabis exposure during adolescence: A uniquely sensitive period for neurobiological effects - PubMed

152. Effects of Acute Drug Administration on Emotion: A Review of Pharmacological MRI Studies - PubMed

153. Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder - PMC

154. Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review - PMC

155. Medical Cannabis for Headache Pain: a Primer for Clinicians - PubMed

156. Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment - PMC

157. Metabolic Consequences of Gestational Cannabinoid Exposure - PMC

158. Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol | Cannabis and Cannabinoid Research

159. Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition - PMC

160. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome - PubMed

161. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC - PubMed

162. Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study - PubMed

163. Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients - PubMed

164. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review | SpringerLink

165. Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population - PubMed

166. Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment - PubMed

167. Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis - Freeman - 2021 - Addiction - Wiley Online Library

168. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis - Journal of the American Pharmacists Association

169. Effectiveness of Cannabinoids for Treatment of Dementia: A Systematic Review of Randomized Controlled Trials - PubMed

170. A Secondary Analysis from a Randomized Trial on the Effect of Plasma Tetrahydrocannabinol Levels on Pain Reduction in Painful Diabetic Peripheral Neuropathy - PubMed

171. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis - The Lancet Psychiatry

172. The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review - PMC

173. Cannabis for Pediatric Epilepsy - PubMed

174. Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy - PubMed

175. Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury | Trauma Surgery & Acute Care Open

176. IJMS | Free Full-Text | Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy

177. The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study - PubMed

178. Delta-9 THC can be detected and quantified in the semen of men who are chronic users of inhaled cannabis - PubMed

179. Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder - PubMed

180. Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies - PMC

181. Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties - PubMed

182. The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression - PubMed

183. The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review - PubMed

184. Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer - PubMed

185. A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report | Journal of Medical Case Reports | Full Text

186. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action - PMC

187. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse - PMC

188. Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission? - PMC

189. Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review - PubMed

190. Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions - PMC

191. Acute and chronic effects of Δ9-tetrahydrocannabinol (THC) on cerebral blood flow: A systematic review - PubMed

192. Acute human exposure assessment to tetrahydrocannabinol (Δ9-THC) - PubMed

193. The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials - ScienceDirect

194. Cannabis Improves Obsessive-Compulsive Disorder—Case Report and Review of the Literature - PMC

195. Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies - PMC

196. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence - PubMed

197. Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity? | mSphere

198. Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients - RR Zafar, AK Schlag, DJ Nutt, 2020

199. https://bedrocan.com/wp-content/uploads/the-use-of-medical-grade-cannabis-in-italy-for-drug-resistant-epilepsy-pane_2020.pdf

200. Letter to the Editor: Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs | Cannabis and Cannabinoid Research

201. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI - PMC

202. Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020 - PMC

203. Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI) - PMC

204. A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors - PMC

205. Can Cannabis Cure Cancer? | Adolescent Medicine | JAMA Oncology | JAMA Network

206. Cannabinoids and Chronic Liver Diseases - PMC

207. Medicinal Use of Cannabis in Children and Pregnant Women - PMC

208. Molecules | Free Full-Text | It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets

209. Sedation challenges in patients with E-cigarette, or vaping, product use-associated lung injury (EVALI) - PubMed

210. Mapping cannabis potency in medical and recreational programs in the United States | PLOS ONE

211. https://mybestbudca.com/wp-content/uploads/1-s2.0-S0195561618300871-main.pdf

212. Marijuana Use in Pregnancy: A Review - PubMed

213. The neuropsychopharmacology of cannabis: A review of human imaging studies - PubMed

214. Cannabis Use and the Risk for Psychosis and Affective Disorders - PubMed

215. Cannabis and psychosis: triangulating the evidence - The Lancet Psychiatry

216. Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever - PMC

217. Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review - PMC

218. New Prospect for Cancer Cachexia: Medical Cannabinoid - PMC

219. Pharmacotherapies for cannabis dependence - PubMed

220. Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry - PMC

221. Insights into the role of cannabis in the management of inflammatory bowel disease - PMC

222. Cannabis and Hearing Care: Hearing Loss and Tinnitus : The Hearing Journal

223. Cannabinoids and inflammation: implications for people living with HIV - PubMed

224. The Association Between Tetrahydrocannabinol and Lower Urinary Tract Symptoms Utilizing the National Health and Nutrition Examination Survey - PubMed

225. Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies - PubMed

226. https://discoveriesjournals.org/discoveries/D.2019.02.OACS.Walkaden.pdf

227. The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review - PMC

228. The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond - ScienceDirect

229. Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders - PubMed

230. Nabilone administration in refractory chronic diarrhea: a case series - PMC

231. Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer's Dementia: A Clinical Case Report - PubMed

232. Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report - PubMed

233. Should Oncologists Recommend Cannabis? - PubMed

234. Cannabinoid Use in Patients With Gastroparesis and Related Disorders: Prevalence and Benefit - PubMed

235. (PDF) Pharmacodynamics of cannabinoids

236. Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms - PMC

237. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials - PubMed

238. Medical Cannabis for the Treatment of Dementia: A Review of Clinical Effectiveness and Guidelines - NCBI Bookshelf

239. Neurological Improvement with Medical Cannabis in a Progressive Supranuclear Palsy Patient: A Case Report - PMC

240. Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting - PubMed

241. Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer - PMC

242. A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC

243. Biphasic effects of THC in memory and cognition - PubMed

244. Standardized cannabis in multiple sclerosis: a case report - PMC

245. High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis - PubMed

246. Frontiers | Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

247. Vaping Cannabis and Chronic Obstructive Pulmonary Disease | Annals of the American Thoracic Society

248. Article with this PMCID is not available - PMC

249. Article with this PMCID is not available - PMC

250. Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection - PMC

251. Multiple Sclerosis, Cannabis Use, and Clinical Disability: A Preliminary [18F]-Fluorodeoxyglucose Positron Emission Tomography Study - PMC

252. Marijuana and Psychosis: Policy Implications for Treatment Providers - PubMed

253. A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol - PMC

254. Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation - PubMed

255. Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer - PMC

256. Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement - PMC

257. Severe motor and vocal tics controlled with Sativex® - PubMed

258. Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases - PMC

259. Neuroprotection by (Endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases - PMC

260. Cannabis‐based medicines for chronic neuropathic pain in adults - PMC

261. Transfer of Inhaled Cannabis Into Human Breast Milk - PubMed

262. A selective review of medical cannabis in cancer pain management - PubMed

263. Cannabis, Cannabinoids, and Sleep: a Review of the Literature - PubMed

264. Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) - PMC

265. Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity - PubMed

266. Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis - PMC

267. Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis - PubMed

268. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome - PubMed

269. An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of Jejunum on the Way to Unravel Her Hyperemesis Enigma - PubMed

270. Research paper: Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity - PMC

271. Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study - PubMed

272. THC:CBD in Daily Practice: Available Data from UK, Germany and Spain - PubMed

273. THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms - PubMed

274. A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis - PubMed

275. High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana - PMC

276. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials - PubMed

277. Cannabis – the Israeli perspective

278. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists - PubMed

279. Effects of Cannabinoids on T-cell Function and Resistance to Infection - PMC

280. The endocannabinoid system and its therapeutic implications in rheumatoid arthritis - PubMed

281. Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics - PMC

282. Effect of marijuana use on outcomes in traumatic brain injury - PubMed

283. Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review - PubMed

284. Early phytocannabinoid chemistry to endocannabinoids and beyond - PubMed

285. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review - PubMed

286. Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation - PMC

287. The endocannabinoid system and the brain - PubMed

288. Towards a better cannabis drug - PMC

289. (PDF) Would some cannabinoids ameliorate symptoms of autism?

290. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities - PMC

291. Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease? - Journal of Pain and Symptom Management

292. Dramatic improvement of refractory Isaacs' syndrome after treatment with dronabinol - PubMed

293. Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report - PubMed

294. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease - PubMed

295. Treatment of a hyperkinetic movement disorder during pregnancy with dronabinol - PubMed

296. Cannabinoids for Tourette's Syndrome - PubMed

297. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb - PubMed

298. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis - PubMed

299. Current Status of Cannabis Treatment of Multiple Sclerosis with an Illustrative Case Presentation of a Patient with MS, Complex Vocal Tics, Paroxysmal Dystonia, and Marijuana Dependence Treated with Dronabinol | CNS Spectrums | Cambridge Core

300. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities - PubMed

301. Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study - PubMed

302. Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain: Expert Opinion on Pharmacotherapy: Vol 7, No 5

303. Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension: a case report - PubMed

304. Multiple sclerosis may disrupt endocannabinoid brain protection mechanism | PNAS

305. Sativex for the management of multiple sclerosis symptoms - PubMed

306. https://www.ukcia.org/research/CannabinoidsInBipolarAffectiveDisorder.pdf

307. Cannabinoids: between neuroprotection and neurotoxicity - PubMed

308. Cannabinoid agonists in the treatment of blepharospasm--a case report study - PubMed

309. Synergistic interactions between cannabinoid and opioid analgesics - ScienceDirect

310. A Case of Cannabinoid Rotation in a Young Woman With Chronic Cystitis - Journal of Pain and Symptom Management

311. Respiratory and immunologic consequences of marijuana smoking - PubMed

312. Tetrahydrocannabinol and endocannabinoids in feeding and appetite - PubMed

313. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review | The BMJ

314. Pain relief with oral cannabinoids in familial Mediterranean fever - PubMed

315. Nabilone in the treatment of multiple sclerosis

316. Recent clinical experience with dronabinol - PubMed

317. Endocrine effects of marijuana in the male: preclinical studies - PubMed

318. Body Temperature: Regulation, Drug Effects, and Therapeutic Implications - Google Books

319. (PDF) Toward drugs derived from Cannabis

320. Marijuana : medical papers, 1839-1972 - NLM Catalog - NCBI

321. Delta‐8‐ and delta‐9‐tetrahydrocannabinol; Comparison in man by oral and intravenous administration - Hollister - 1973 - Clinical Pharmacology & Therapeutics - Wiley Online Library